🇺🇸 FDA
Pipeline program

Human Erythropoiesis Injection (CHO cell)

SYSS-SSS06-HD-III-01

Phase 3 small_molecule active

Quick answer

Human Erythropoiesis Injection (CHO cell) for Kidney Failure, Chronic is a Phase 3 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Sunshine Biopharma
Indication
Kidney Failure, Chronic
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials